Principal Investigator
Eugene Schiff
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20201162
Clinical Trial Summary
A Phase 2, Randomized, Double-Blind, Placebo-Controlled,Parallel Group Study to Evaluate Efficacy, Safety andTolerability of HM15211 Treatment for 12 Months in Subjectswith Biopsy Confirmed NASH
Phase
Phase II
Funding Agency/Sponsor
Industry
Disease
Non-Alcoholic Fatty Liver Disease (NAFLD)
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu